Vivus Obesity Drug Works?
Filed in archive Weight on December 15, 2008
Vivus Inc. - the maker of the obesity drug Qnexa - has reported that obese patients treated with the highest dose of its experimental drug Qnexa on average lost 9.2 percent of their weight.
Such were the findings from the first of three late-stage trials involving Qnexa - a mixture of phentermine (half of the recalled fen-phen diet pill) and the epilepsy drug Topamax (topiramate).
Vivus said the 28-week, 756-patient study met its main goal of superior weight loss with two different doses of Qnexa, compared with the drug's individual components and a placebo pill. Patients in the placebo group on average lost 1.7 percent of their weight, while patients on "mid-dose" Qnexa lost 8.5 percent.
Hmmm...I don't 9.2 percent is a big loss of weight to consider the pill as working. What do you think?
Read the full report here and here.
Permalink: Vivus Obesity Drug Works?
Tags: diet pill Vivus Qnexa health obesity+drug drug+works vivus+obesity
Vote for Vivus Obesity Drug Works?:
|
Rating: 9.67 out of 3 vote(s) cast.
|
Response from:
Ajlouny
(12/25/08 2:33am)
How do they know that there is no severe side effects to this drug that is not similar to Fen-Fen. Don't want to regret taking a diet pill.
Response from:
Jessica
(10/26/09 10:54am)
You don't know what you're talking about. Losing almost 10% of your weight is HUGE. especially if it's JUST from the drug itself. Other drugs that advertise that they do more than 10% body weight are either unhealthy or phony.
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Follow us on Twitter! |
Most Popular
Accidents
Arthritis
Beauty
Best of
Birth Control
Bone Health
Breast Cancer
Cancer, General
CFS and Fibromyalgia
Child Health
Diabetes
Did you know
Diet and Food
Digestive Health
Exercise
Eye Health
General Health
Heart and Stroke
Infertility
Information about